确定接受R-CHOP治疗的新诊断大B细胞淋巴瘤患者的临床病理预后指数。 - Suppr

Identification of a clinicopathologic prognostic index for newly diagnosed large B-cell lymphoma patients treated with R-CHOP.

作者信息

Ni Vincent, Nasta Sunita D, Barta Stefan K, Schuster Stephen J, Chong Elise A, Svoboda Jakub, Morrissette Jennifer J D, Barlev Ashley, Bagg Adam, Priore Salvatore F, Landsburg Daniel J

机构信息

School of Arts and Sciences, University of Pennsylvania, Philadelphia.

Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia.

出版信息

Haematologica. 2025 Apr 1;110(4):1023-1027. doi: 10.3324/haematol.2024.286560. Epub 2024 Nov 28.

DOI:10.3324/haematol.2024.286560

PMID:39605216

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11959230/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7ca/11959230/9e23427e54a0/1101023.fig1.jpg

相似文献

Identification of a clinicopathologic prognostic index for newly diagnosed large B-cell lymphoma patients treated with R-CHOP.

Haematologica. 2025 Apr 1;110(4):1023-1027. doi: 10.3324/haematol.2024.286560. Epub 2024 Nov 28.

Clinical characteristics and outcomes of patients with diffuse large B cell lymphoma treated with R-CHOP-like or CHOP-like regimens: an 8-year experience from a single center.

Ann Palliat Med. 2020 Jul;9(4):1442-1452. doi: 10.21037/apm-19-589. Epub 2020 Jul 2.

Identification of Very Low-Risk Subgroups of Patients with Primary Mediastinal Large B-Cell Lymphoma Treated with R-CHOP.

Oncologist. 2021 Jul;26(7):597-609. doi: 10.1002/onco.13789. Epub 2021 Jun 17.

External validation and comparison of IPI, R-IPI, and NCCN-IPI in diffuse large B-cell lymphoma patients treated with R-CHOP to predict 2-year progression-free survival.

Hematology. 2022 Dec;27(1):1237-1245. doi: 10.1080/16078454.2022.2147916.

[The prognostic value of the international prognostic index, the national comprehensive cancer network IPI and the age-adjusted IPI in diffuse large B cell lymphoma].

Zhonghua Xue Ye Xue Za Zhi. 2018 Sep 14;39(9):739-744. doi: 10.3760/cma.j.issn.0253-2727.2018.09.007.

[A comparative study of induction chemotherapy with or without autologous hematopoietic stem cell transplantation in the treatment of newly diagnosed young medium/high risk diffuse large B cell lymphoma patients].

Zhonghua Xue Ye Xue Za Zhi. 2019 Feb 14;40(2):117-124. doi: 10.3760/cma.j.issn.0253-2727.2019.02.005.

Clinical outcomes in patients with diffuse large B cell lymphoma with a partial response to first-line R-CHOP chemotherapy: prognostic value of secondary International Prognostic Index scores and Deauville scores.

Ann Hematol. 2017 Nov;96(11):1873-1881. doi: 10.1007/s00277-017-3107-6. Epub 2017 Aug 22.

Prognostic significance of pleural or pericardial effusion and the implication of optimal treatment in primary mediastinal large B-cell lymphoma: a multicenter retrospective study in Japan.

Haematologica. 2014 Dec;99(12):1817-25. doi: 10.3324/haematol.2014.111203. Epub 2014 Sep 12.

Correlations between BCL6 rearrangement and outcome in patients with diffuse large B-cell lymphoma treated with CHOP or R-CHOP.

Haematologica. 2010 Jan;95(1):96-101. doi: 10.3324/haematol.2009.007203. Epub 2009 Oct 1.

A single-centre, real-world study of BTK inhibitors for the initial treatment of MYD88 /CD79B diffuse large B-cell lymphoma.

Cancer Med. 2024 Feb;13(4):e7005. doi: 10.1002/cam4.7005.

本文引用的文献

Accurate interpretation of p53 immunohistochemical patterns is a surrogate biomarker for TP53 alterations in large B-cell lymphoma.

BMC Cancer. 2023 Oct 19;23(1):1008. doi: 10.1186/s12885-023-11513-x.

TP53 mutations predict for poor outcomes in patients with newly diagnosed aggressive B-cell lymphomas in the current era.

Blood Adv. 2023 Dec 12;7(23):7243-7253. doi: 10.1182/bloodadvances.2023011384.

Simplified algorithm for genetic subtyping in diffuse large B-cell lymphoma.

Signal Transduct Target Ther. 2023 Apr 10;8(1):145. doi: 10.1038/s41392-023-01358-y.

A 70% cut-off for MYC protein expression in diffuse large B cell lymphoma identifies a high-risk group of patients.

Haematologica. 2020 Nov 1;105(11):2667-2670. doi: 10.3324/haematol.2019.235556.

Prognostic Significance of Rearrangement and Translocation Partner in Diffuse Large B-Cell Lymphoma: A Study by the Lunenburg Lymphoma Biomarker Consortium.

J Clin Oncol. 2019 Dec 10;37(35):3359-3368. doi: 10.1200/JCO.19.00743. Epub 2019 Sep 9.

Molecular High-Grade B-Cell Lymphoma: Defining a Poor-Risk Group That Requires Different Approaches to Therapy.

J Clin Oncol. 2019 Jan 20;37(3):202-212. doi: 10.1200/JCO.18.01314. Epub 2018 Dec 3.

TP53 mutation and survival in aggressive B cell lymphoma.

Int J Cancer. 2017 Oct 1;141(7):1381-1388. doi: 10.1002/ijc.30838. Epub 2017 Jun 26.

P53 expression correlates with poorer survival and augments the negative prognostic effect of MYC rearrangement, expression or concurrent MYC/BCL2 expression in diffuse large B-cell lymphoma.

Mod Pathol. 2017 Feb;30(2):194-203. doi: 10.1038/modpathol.2016.178. Epub 2016 Oct 14.

Front-line, dose-escalated immunochemotherapy is associated with a significant progression-free survival advantage in patients with double-hit lymphomas: a systematic review and meta-analysis.

Br J Haematol. 2015 Aug;170(4):504-14. doi: 10.1111/bjh.13463. Epub 2015 Apr 24.

Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis.

Blood. 2014 Oct 9;124(15):2354-61. doi: 10.1182/blood-2014-05-578963. Epub 2014 Aug 26.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Identification of a clinicopathologic prognostic index for newly diagnosed large B-cell lymphoma patients treated with R-CHOP.

作者信息

Ni Vincent, Nasta Sunita D, Barta Stefan K, Schuster Stephen J, Chong Elise A, Svoboda Jakub, Morrissette Jennifer J D, Barlev Ashley, Bagg Adam, Priore Salvatore F, Landsburg Daniel J

机构信息

School of Arts and Sciences, University of Pennsylvania, Philadelphia.

Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia.

出版信息

Haematologica. 2025 Apr 1;110(4):1023-1027. doi: 10.3324/haematol.2024.286560. Epub 2024 Nov 28.

DOI:10.3324/haematol.2024.286560

PMID:39605216

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11959230/

Abstract

摘要

Identification of a clinicopathologic prognostic index for newly diagnosed large B-cell lymphoma patients treated with R-CHOP.

作者信息

机构信息

出版信息

相似文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Identification of a clinicopathologic prognostic index for newly diagnosed large B-cell lymphoma patients treated with R-CHOP.

作者信息

机构信息

出版信息

相似文献

本文引用的文献